Medtentia International Ltd is happy to announce the appointment of Hannu Syrjälä as the new Chairman of its Board of Directors. Mr. Syrjälä succeeds Tord Lendau as Chairman starting from the 14th of September, 2016. Mr. Syrjälä has over twenty years of experience in different senior...
The long-term data collection for the proof-of-concept study evaluating the Medtentia Annuloplasty Ring (MAR) has recently been completed. The prospective single-arm clinical study assessed MAR safety and performance in 11 adults who underwent mitral valve repair surgery. The collected data is currently being analyzed, and...
Medtentia International Ltd Oy has successfully completed a €8M financing round in March 2015. The round includes a total of €6M in equity from existing and new investors, while the remaining €2M consists of shareholder loans converted into capital. The raised funds will be used mainly...
Medtentia International Ltd Oy today announced that the surgeons at Helsinki University Hospital led by Prof Werkkala have successfully continued to recruit patients for the official second phase of the clinical approval study evaluating the safety and efficacy of the “Medtentia Helix Ring in Adults...